ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Pre-Transplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Chronic Portal Vein Thrombosis

    B. Thornburg, K. Desai, T. Baker, J. Fryer, M. Abecassis, J. Caicedo, L. Kulik, R. Salem.

    Northwestern Memorial Hospital, Chicago, IL.

    Background: Chronic, occlusive portal vein thrombosis (PVT) associated with cirrhosis represents a relative contraindication to liver transplantation (LT) in some centers. From a surgical perspective,…
  • 2015 American Transplant Congress

    AAV-Mediated TIMP-1 Gene Therapy Ameliorates Hepatic Ischemia/Reperfusion Injury

    S. Duarte, T. Fujii, G. Lipshutz, R. Busuttil, A. Coito.

    The Dumont-UCLA Transplant Center, Los Angeles.

    Matrix metalloproteinase-9 (MMP-9) is a key mediator of leukocyte migration across vascular barriers in hepatic ischemia/reperfusion injury (IRI). Tissue inhibitor of metalloproteinase-1 (TIMP-1) is the…
  • 2015 American Transplant Congress

    Interim Results of a Phase 1 Trial of Treg Adoptive Cell Transfer (TRACT) in Living Donor Kidney Transplant Recipients

    J. Leventhal,1 A. LeFever,2 A. Skaro,1 L. Gallon,1 J. Mathew,1 D. Stare,1 I. Konieczna,1 J. He,1 G. Johnson.3

    1Northwestern University, Chicago; 2Northwestern Memorial Hospital, Chicago; 3TRACT Therapeutics Inc., Chicago.

    Therapeutic cell transfer using regulatory T cells (Tregs) in transplant recipients may reduce the need for drug based immunosuppression (IS) and improve long term graft…
  • 2015 American Transplant Congress

    Treatment of Hepatitis C Virus in Kidney Transplant Recipients With Direct Acting Anti-Viral Agents: Early Results in 12 Cases

    A. Sharfuddin,1 T. Taber,1 M. Mujtaba,1 M. Yaqub,1 D. Mishler,1 P. Kwo,2 R. Vuppalanchi.2

    1Medicine/Nephrology, Indiana University, Indianapolis; 2Medicine/Hepatology, Indiana University, Indianapolis.

    Background: Recently approved direct acting antiviral agents (DAA) for treatment of HCV are interferon sparing allowing an attractive treatment option for kidney transplant recipient with…
  • 2015 American Transplant Congress

    Eculizumab in Prevention of Acute Antibody-Mediated Rejection in Sensitized Deceased-Donor Kidney Transplant Recipients: 1-Year Outcomes

    D. Glotz,1 G. Russ,2 L. Rostaing,3 C. Legendre,4 S. Chadban,5 J. Grinyo,6 N. Mamode,7 E. Cozzi,11 Y. Lebranchu,8 S. Sandrini,9 L. Couzi,12 W. Marks.10

    1H St-Louis, Paris, France; 2Ryl Adelaide H, Adelaide, Australia; 3CHU Rangueil, Toulouse, France; 4H Necker, Paris, France; 5Ryl Pr Alfred H, Camperdown, Australia; 6H U deBellvitge, Barcelona, Spain; 7Guy's H, London, United Kingdom; 8H Bretonneau CHU, Tours, France; 9Spedali Cvl di Brescia, Brescia, Italy; 10Alexion, Cheshire; 11Via Giustiniani, Padua, Italy; 12Hopital Pellegrin, CHU Bordeaux, Bordeaux, France.

    Complement activation by preformed DSA is a major mechanism of acute antibody-mediated rejection (aAMR) in sensitized kidney transplant recipients (KTR). We previously reported interim study…
  • 2015 American Transplant Congress

    Monocyte Recruitment to HLA Class I Antibody-Activated Endothelial Cells Is Dependent Upon mTOR

    S. Salehi, E. Reed.

    Pathology & Laboratory Medicine, UCLA, Los Angeles, CA.

    Aim: Antibody-mediated rejection (AMR) persists as a major issue affecting solid organ transplants. The purpose of this study was to investigate the proximal signaling events…
  • 2015 American Transplant Congress

    High-Resolution Perfusion Mapping to Detect Heart Transplant Rejection Using Contrast Enhance Ultrasound

    K. Fischer,1,2 S. Ohori,2 F. Meral,1 S. Giannini,2 K. Hoffmeister,2 H. Athar,2 T. Ichimura,2 R. Smith,3 M. Giverts,2 F. Jolesz,1 R. Abdi.2

    1Radiology, Brigham and Women's Hospital, Boston; 2Medicine, Brigham and Women's Hospital, Boston; 3Pathology, Massachusetts General Hospital, Boston.

    Background: One of the key unmet needs in heart transplantation is an effective and accurate, non-invasive tool to diagnose acute and chronic heart transplant rejection.…
  • 2015 American Transplant Congress

    CXCR4-SDF1α Blockade Reduces the Severity of Murine Heart Allograft Rejection

    X. Wang,1 J. Fu,1 B. Wilde,1 L. Jing,1 J. Zhu,1 A. Kribben,1 O. Witzke,1 A. Hoerning.2,3

    1Department of Nephrology, University Hospital Essen, University Duisburg-Essen, Essen, Germany; 2Department of Pediatrics II, University Hospital Essen, University Duisburg-Essen, Essen, Germany; 3Department of Pediatric and Adolescent Medicine, University Hospital Erlangen, Friedrich-Alexander University Erlangen, Erlangen, Germany.

    Introduction: The interaction of the CXCR4/SDF1α axis plays a critical role in the retention of hematopoietic stem cells in bone marrow. We hypothesized that the…
  • 2015 American Transplant Congress

    Proteasome Activation During Renal Cold Storage and Transplantation: A Novel Pathway for Mitochondrial Destruction?

    N. Parajuli, L. MacMillan-Crow.

    Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR.

    Purpose: Renal cold storage (CS) is considered to be an alloantigen-independent risk factor for long-term transplant outcome. The precise molecular mechanisms responsible for CS-related renal…
  • 2015 American Transplant Congress

    Bariatric Surgery Prolongs Allograft Survival by Promoting Th2 Conditions

    M. Quante, A. ElKhal, H. Rodriguez, R. Abdi, F. Krenzien, H. Uehara, S. Tullius.

    Division of Transplant Surgery and Transplant Surgery Research Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston.

    Background: Obesity is linked to chronic low-grade inflammation. We hypothesized that I) obesity will accelerate allograft rejection linked to pro-inflammatory immune responses and that II)…
  • « Previous Page
  • 1
  • …
  • 1385
  • 1386
  • 1387
  • 1388
  • 1389
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences